LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Top 2 FTSE 100 shares to buy for 2023
Investing Articles
If I’d invested £500 in AstraZeneca shares 2 years ago, here’s how much I’d have now!
Investing Articles
Best British shares to buy in November
Investing Articles
What on earth is going on with the AstraZeneca share price?
Investing Articles
6 super investors hold this FTSE 100 stock. Should I buy it too?
Investing Articles
Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!
Investing Articles
2 FTSE 100 shares to buy in the UK stock market crash
Investing Articles
2 no-brainer value stocks I think I’ll buy for Q4
Investing Articles
If I’d invested £1,000 in AstraZeneca shares at the start of 2022, here’s what I’d have now
Investing Articles
1 FTSE 100 stock that should continue to outperform long term
Page
Top UK Blue-Chip Stocks of 2025